The trademark application was filed by Novartis AG, a corporation established under the laws of the Swiss Confederation (the "Applicant"). The application was published for oppositions on June 28, 2022, and it was registered by office on October 5, 2022 without any oppositions.
The application was filed in English (French was selected as the second language).